Keynote Speakers

Tuesday, April 16

9:00 a.m. – 10:00 a.m.


KEYNOTE: Creating Big Change in Small Ways

Keith Guggenberger
Senior Vice-President of Operations
Starkey Hearing Technologies

Starkey is a world leader in developing and manufacturing hearing technologies and related accessories. As an executive with broad responsibilities, Keith leads innovation initiatives that develop technologies and drive change in the global manufacturing of medical devices. Guggenberger will share some of the experiences and challenges faced in creating and deploying technologies through microelectronics and rapid device manufacturing. His keynote will explore how to combine leadership, technology and innovation to accomplish big organizational change and growth in small ways.

 

Wednesday, April 17

9:00 a.m. – 10:00 a.m.


MicroManufacturing KEYNOTE: Economic Outlook

William Strauss
Senior Economist and Economic Advisor
Federal Reserve Bank of Chicago

The “Great Recession” of 2008 and 2009 ended in the middle of 2009 with significant impacts on the economy. The economy experienced outsized losses in the housing, manufacturing and jobs. Yet, what should be a robust recovery is not occurring, nor expected. Unemployment remains very high, consumers are saving at an increased pace, limiting the growth of consumer spending. Credit conditions, while significantly improved from what existed during the recession, remain relatively tight and will act as a headwind to growth. Strauss will look at the performance of the overall macro economy with specific attention paid to key economic sectors and indicators.

 

Medical Manufacturing Innovations KEYNOTE: Medical Manufacturing Innovation in a Changing Landscape

Dale Wahlstrom
President and CEO
LifeScience Alley and the BioBusiness Alliance of Minnesota

The new Medical Device Innovation Consortium’s mission is to promote innovation through the application of regulatory science to expedite new product development and review. With FDA review changes and the implementation of the Affordable Healthcare Act, what are some of the implications? What does this mean for manufacturing? How will your efforts to use new technologies, tools and process improvements be impacted? Wahlstrom will share his thoughts on these and more based on his more than 24 years with Medtronic, CRDM Venture programs and now as President, CEO of Life Science Alley and The BioBusiness Alliance of Minnesota.